Heres what researchers have discovered and a peek at what future studies may show
Safety Considerations The FDA has identified specific safety concerns with CJC-1295
Are GLP-1 weight-loss drugs safe for older adults?, AAMC (2025) FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight, Food and Drug Administration (2024) Health risks of overweight and obesity, National Institute of Diabetes and Digestive and Kidney Diseases (2023) Rybelsus, Novo Nordisk Semaglutide injection (weight management), Cleveland Clinic Semaglutide (subcutaneous route), Mayo Clinic U.S
Puberty Menopause
Schick RR, vorm Walde T, Zimmermann JP, Schusdziarra V, Classen M
I mean, because again, we had a massive November, and we expected to do something similar in December, and it was nowhere close